Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,373Revenue $M5.2Net Margin (%)-2,335.7Altman Z-Score22.4
Enterprise Value $M1,042EPS $-1.3Operating Margin %-2,406.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-2,335.7Higher ROA y-yY
Price/Book4.010-y EBITDA Growth Rate %--Quick Ratio12.7Cash flow > EarningsY
Price/Sales2465-y EBITDA Growth Rate %--Current Ratio12.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-38.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-42.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M98.5ROIC % (ttm)-845.8Gross Margin Increase y-yN

Gurus Latest Trades with CLDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CLDXJoel Greenblatt 2015-06-30 Sold Out -0.01%$23.67 - $30.1
($26.5)
$ 13.93-47%Sold Out0
CLDXJoel Greenblatt 2015-03-31 Buy 0.01%$18.29 - $31.78
($23.85)
$ 13.93-42%New holding35,223
CLDXFirst Eagle Investment 2014-12-31 Add0.01%$12.55 - $20.93
($16.61)
$ 13.93-16%Add 123.82%559,542
CLDXFirst Eagle Investment 2014-09-30 Buy 0.01%$12.05 - $17.57
($14.51)
$ 13.93-4%New holding250,000
CLDXFirst Eagle Investment 2014-03-31 Sold Out -0.01%$16.95 - $31.59
($25.6)
$ 13.93-46%Sold Out0
CLDXFirst Eagle Investment 2013-12-31 Reduce-0.04%$21.51 - $36.71
($25.51)
$ 13.93-45%Reduce 75.45%135,000
CLDXFirst Eagle Investment 2013-06-30 Reduce-0.02%$11.01 - $16.09
($13.13)
$ 13.936%Reduce 45.89%665,560
CLDXGeorge Soros 2012-06-30 Sold Out -0.06%$3.9 - $5.26
($4.39)
$ 13.93217%Sold Out0
CLDXFirst Eagle Investment 2012-06-30 Add0.02%$3.9 - $5.26
($4.39)
$ 13.93217%Add 260.87%1,660,000
CLDXGeorge Soros 2012-03-31 Buy 0.06%$2.77 - $5.46
($4)
$ 13.93248%New holding803,200
CLDXFirst Eagle Investment 2012-03-31 Add0.01%$2.77 - $5.46
($4)
$ 13.93248%Add 360.00%460,000
CLDXFirst Eagle Investment 2011-12-31 Reduce$2.11 - $3.21
($2.7)
$ 13.93416%Reduce 71.43%100,000
CLDXFirst Eagle Investment 2011-06-30 Buy 0.01%$3.03 - $4.46
($3.75)
$ 13.93271%New holding350,000
CLDXFirst Eagle Investment 2010-03-31 Sold Out $4.35 - $6.39
($4.93)
$ 13.93183%Sold Out0
CLDXFirst Eagle Investment 2009-12-31 Buy $4.2 - $5.66
($4.78)
$ 13.93191%New holding100,000
CLDXFirst Eagle Investment 2009-09-30 Sold Out $4.95 - $7.93
($6.35)
$ 13.93119%Sold Out0
CLDXFirst Eagle Investment 2009-06-30 Buy $6.81 - $11.22
($8.56)
$ 13.9363%New holding50,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CLDX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CLDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ELLBERGER LARRYDirector 2015-08-25Buy5,000$14-0.5view
ELLBERGER LARRYDirector 2015-08-20Buy5,000$15-7.13view
ELLBERGER LARRYDirector 2015-08-18Buy5,000$15.95-12.66view
ELLBERGER LARRYDirector 2015-08-13Buy5,000$16.59-16.03view
Marucci Anthony SPresident and CEO 2015-08-13Buy5,800$16.81-17.13view
CATLIN AVERY WSr. VP & CFO 2015-06-15Sell25,000$24.59-43.35view
van den Broek RichardDirector 2014-12-17Sell0$0-43.35view
LIPTON KAREN SHOOSDirector 2013-12-06Sell17,728$24.5-43.14view
PENNER HARRY JRDirector 2013-12-06Sell17,728$24.5-43.14view
ELLBERGER LARRYDirector 2013-12-06Sell17,728$24.5-43.14view

Quarterly/Annual Reports about CLDX:

    News about CLDX:

    Articles On GuruFocus.com
    Cantor Fitzgerald and Brean Capital Positive on Celldex Therapeutics Following Positive Data For Bra Jun 01 2015 
    Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
    Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 
    Cowen & Co Remains Bullish on Celldex Therapeutics Following FDA 'Breakthrough' Approval Feb 24 2015 
    CLDX up 223%, Cohen Gains Big Apr 23 2013 
    Steve Cohen Increases Celldex Up 145% Apr 06 2013 
    comment on CLDX Mar 06 2013 
    5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
    CELLDEX THERAPEUTICS, INC (CLDX) CEO Anthony S Marucci buys 12,000 Shares Sep 13 2010 
    Weekly CFO Buys Highlight: GNMK, RTIX, BKOR, PTEK, CLDX Sep 12 2010 

    More From Other Websites
    Celldex (CLDX) Shows Strength: Stock Adds 8.2% in Session Aug 26 2015
    CELLDEX THERAPEUTICS, INC. Financials Aug 21 2015
    Biotech Stock Mailbag: Celldex, Bluebird, Kite, Inovio Aug 21 2015
    ​Celldex and the limits of ‘overall survival benefit’ in cancer trials Aug 13 2015
    10-Q for Celldex Therapeutics, Inc. Aug 12 2015
    Celldex Q2 Loss Narrower than Expected, Pipeline in Focus - Analyst Blog Aug 11 2015
    Edited Transcript of CLDX earnings conference call or presentation 10-Aug-15 8:30pm GMT Aug 10 2015
    Celldex reports 2Q loss Aug 10 2015
    Celldex reports 2Q loss Aug 10 2015
    CELLDEX THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 10 2015
    Celldex Reports Second Quarter 2015 Results Aug 10 2015
    Q2 2015 Celldex Therapeutics Inc Earnings Release - After Market Close Aug 10 2015
    Will Celldex (CLDX) Disappoint Estimates in Q2 Earnings? - Analyst Blog Aug 04 2015
    Celldex to Report Second Quarter 2015 Financial Results and Host Corporate 2015 Objectives Update... Aug 04 2015
    Celldex Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference Jul 02 2015
    Celldex Therapeutics Appoints Richard Wright as Chief Commercial Officer Jul 01 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK